ACADIA Pharmaceuticals Inc. (ACAD) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for ACADIA Pharmaceuticals Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
ACADIA Pharmaceuticals Inc. (ACAD) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $3.5B. It trades at $20.32, up 0.74% today, at 9.2 times earnings. Its overall quality score is 81 out of 100, ranked against the whole US market. 14 analysts' average target of $31.43 implies +54.7% from today's price. Kronos AI's 30-day forecast is +10.5% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $31.43 |
| Low – high | $23.00 – $37.00 |
| Analysts | 14 |
| Upside to average | +54.7% |
Kronos AI 30-day forecast
| Expected close | $22.29 (+10.5%) |
| Likely range | +8.9% … +13.9% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 81 |
| Solvency | 78 |
| Growth | 85 |
| Overall | 81 |
| P/E | 9.2 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator